Procept Biorobotics Corp Stock Technical Analysis
| PRCT Stock | USD 27.80 3.63 15.02% |
As of the 12th of March 2026, the last recorded price for Procept Biorobotics is 27.80 per share. Primary technical drivers reflect Variance of 16.25, coefficient of variation of -1,011, and Risk Adjusted Performance of -0.07. Quantitative analysis incorporates volatility metrics and price behavior to assess directional bias. Metrics are compared to industry averages to assess relative positioning.
Procept Biorobotics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Procept, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProceptProcept Biorobotics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Procept Biorobotics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 32.27 | Strong Buy | 10 | Odds |
Procept Biorobotics Corp current and past analyst recommendations are summarized from multiple research sources. Average analyst consensus is included for context. Analyst ratings for Procept Biorobotics Corp aggregate the views of institutional research teams who conduct deep fundamental analysis, build financial models, and speak directly with Procept's management. Consensus upgrades or downgrades often have meaningful short-term impact on the stock price.
Earnings Share -1.72 | Revenue Per Share | Quarterly Revenue Growth 0.119 | Return On Assets | Return On Equity |
The market value of Procept Biorobotics Corp is measured differently than book value, which reflects Procept accounting equity. Procept Biorobotics' market capitalization is 1.36 B. With a P/B ratio of 3.73, the market values Procept Biorobotics well above its book equity. Enterprise value stands at 1.15 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Procept Biorobotics' intrinsic value and market price are different measures derived from different inputs. For Procept Biorobotics, key inputs include a P/B ratio of 3.73, a profit margin of -31.02%, ROE of -24.89%, and revenue of 308.05 M. Trading price represents the transaction level agreed by market participants.
Procept Biorobotics 'What if' Analysis
Running a what-if backtest on Procept Biorobotics Corp gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Procept Biorobotics' historical reward profile was stable enough to support the current thesis.
| 12/12/2025 |
| 03/12/2026 |
If you invested 0.00 in Procept Biorobotics on December 12, 2025 and closed the position today, you would earn 0.00 in aggregate gains. The change equals a 0.0% return on investment in Procept Biorobotics on balance over a 90 day window. Procept Biorobotics is related to or competes with Twist Bioscience, Guardian Pharmacy, Mesoblast, Qilian International, Quidel, Edgewise Therapeutics, and Clover Health. Peer context can support comparative analysis. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology More
Procept Biorobotics Upside and Downside Indicators Signals
Upside and downside indicators for Procept Biorobotics summarize momentum balance and potential range context for the stock. The signals are presented as informational context for recent price movement.
| Information Ratio | -0.1 | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | -5.21 | |||
| Potential Upside | 6.78 |
Procept Biorobotics Market Risk Indicators Signals
Market risk indicators summarize volatility and return dispersion for Procept Biorobotics. This view provides neutral context for risk and variability.| Risk Adjusted Performance | -0.07 | |||
| Jensen Alpha | -0.40 | |||
| Total Risk Alpha | -0.30 | |||
| Treynor Ratio | -2.25 |
The concept of mean reversion suggests that Procept Biorobotics' price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
Procept Biorobotics Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.07 | |||
| Market Risk Adjusted Performance | -2.24 | |||
| Mean Deviation | 2.86 | |||
| Coefficient Of Variation | -1,011 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.25 | |||
| Information Ratio | -0.1 | |||
| Jensen Alpha | -0.40 | |||
| Total Risk Alpha | -0.30 | |||
| Treynor Ratio | -2.25 | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | -5.21 | |||
| Potential Upside | 6.78 | |||
| Skewness | 0.1704 | |||
| Kurtosis | 3.83 |
Procept Biorobotics Corp Backtested Returns
Over the selected 3 months, Procept Biorobotics demonstrates a low volatility profile. It exhibits a Sharpe Ratio (Efficiency) of -0.0728, indicating negative risk-adjusted returns over the last 3 months. Technical screening detected twenty-four indicators influencing risk dynamics. Please analyze metrics such as Variance of 16.25, risk-adjusted performance of -0.07, and Coefficient Of Variation of -1,011 to assess dispersion and downside exposure. The company owns a Beta (Systematic Risk) of 0.18, which conveys relatively modest fluctuations relative to the market. As returns on the market increase, Procept Biorobotics' returns are expected to increase less than the market. However, during a bear market, the loss from holding Procept Biorobotics is expected to be smaller as well. At this point, Procept Biorobotics Corp has a negative expected return of -0.33%. Please make sure to confirm Procept Biorobotics' the relationship between the Kurtosis and day typical price, to decide if Procept Biorobotics Corp's performance from the past will be repeated in the future.
Auto-correlation | 0.68 |
Good predictability
Procept Biorobotics Corp exhibits good predictability. Autocorrelation measures the degree of predictability between Procept Biorobotics time series from 12th of December 2025 to 26th of January 2026 and from 26th of January 2026 to 12th of March 2026. The stronger the relationship between the current interval and its lagged values, the more accurately future price behavior of Procept Biorobotics Corp may be projected. A serial correlation of 0.68 indicates that around 68.0% of current Procept Biorobotics price fluctuations can be explained by its historical price movements.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 3.61 |
Procept Biorobotics technical stock analysis uses price and volume transformations to study behavior. The model references moving averages, relative strength, and price correlation signals.
Procept Biorobotics Corp Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Procept Biorobotics Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Procept Biorobotics Technical Analysis
Technical analysis of Procept Biorobotics evaluates price structure, momentum, and volatility clustering. Volume and liquidity conditions influence signal reliability. Lower liquidity may increase execution variability. Procept Biorobotics has a market cap of 1.36 B, ROE of -24.89%. 
Gabriel Shpitalnik · Member of Macroaxis Editorial Board
Unless otherwise specified, financial data for Procept Biorobotics Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Procept Biorobotics Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Procept Stock is Curated By:
Gabriel Shpitalnik · Member of Macroaxis Editorial BoardProcept Biorobotics Technical Indicators
A technical review of Procept Biorobotics Corp can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.07 | |||
| Market Risk Adjusted Performance | -2.24 | |||
| Mean Deviation | 2.86 | |||
| Coefficient Of Variation | -1,011 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.25 | |||
| Information Ratio | -0.1 | |||
| Jensen Alpha | -0.40 | |||
| Total Risk Alpha | -0.30 | |||
| Treynor Ratio | -2.25 | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | -5.21 | |||
| Potential Upside | 6.78 | |||
| Skewness | 0.1704 | |||
| Kurtosis | 3.83 |
Procept Biorobotics March 12, 2026 Daily Trend Indicators
A technical review of Procept Biorobotics Corp can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Accumulation Distribution | 0.14 | ||
| Daily Balance Of Power | 0.95 | ||
| Rate Of Daily Change | 1.15 | ||
| Day Median Price | 25.90 | ||
| Day Typical Price | 26.53 | ||
| Price Action Indicator | 3.72 | ||
| Market Facilitation Index | 3.81 |
Additional Tools for Procept Stock Analysis
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |